Agios Pharmaceuticals, Inc. AGIO

32.58 (0.32) (0.97%) as of 25 Sep
Market cap
$2.0B
P/E
0.0×
Growth Flags show if company had growth for consecutive years

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Cash and Short Term Investments
854.43 893.71 776.93 783.12 1,020.02 572.93 564.88 585.30 423.94 541.31
Receivables
10.58 4.11 2.81 2.21 4.38 25.40 15.32 10.44 3.67 8.31
Inventory
32.92 27.62 19.08 8.49 — 14.70 7.33 0.87 — —
Total current assets
942.05 965.60 833.84 832.77 1,064.23 636.68 611.70 613.78 445.26 559.89
Property, Plant, Equpment (Net)
10.78 11.68 15.38 22.99 28.92 30.82 31.47 24.32 24.43 25.34
Long-Term Investments
310.01 638.32 29.44 313.87 266.38 97.61 152.93 220.12 143.81 32.25
Long-term assets (Other)
3.93 4.72 4.06 3.96 2.90 3.00 0.00 0.24 0.89 1.62
Total non-current assets
355.17 697.60 103.28 405.95 373.51 216.28 279.04 244.68 169.14 59.20
Total Assets
1,297.23 1,663.20 937.12 1,238.72 1,437.74 852.95 890.74 858.46 614.40 619.09
Accounts Payable
18.36 16.64 9.78 18.62 16.70 17.72 21.90 17.88 22.77 17.11
Accrued Expenses
45.46 46.86 43.17 30.35 31.97 30.80 53.14 42.15 34.03 32.00
Current Part of Capital Lease
— — — — 0.33 0.32 0.27 — — —
Current Part of Taxes to Pay
0.00 0.87 0.00 — — — — — — —
Current Revenue (Deferred)
— — — — — — 10.93 33.48 38.14 39.33
Total current liabilities
82.21 81.16 67.96 62.63 59.83 94.39 92.89 93.50 94.94 88.43
Long Term Debt (Total)
— — — 72.00 0.28 0.33 0.67 — — —
Non-current Revenue (Deferred)
— — — — — — 50.58 77.42 143.95 172.07
Non-current Liabilities (Other)
0.09 0.88 1.16 3.28 — 261.00 0.00 18.00 18.00 17.77
Total non-current liabilities
21.91 41.09 58.14 75.28 85.94 359.06 157.33 77.42 143.95 172.07
Total liabilities
104.11 122.24 126.10 137.90 145.76 453.45 250.21 170.92 238.89 260.50
Additional Paid In Capital
2,555.04 2,493.81 2,436.52 2,386.33 2,334.35 2,242.80 2,156.36 1,794.28 1,174.90 842.01
Common Stock (Net)
0.08 0.07 0.07 0.07 0.07 0.07 0.07 0.06 0.05 0.04
Retained Earnings
(561.70) (148.92) (822.65) (470.56) (238.76) (1,843.47) (1,516.10) (1,104.63) (798.06) (483.15)
Treasury Stock
802.49 802.49 802.49 802.49 802.49 — — — — —
Common Equity (Total)
1,193.11 1,540.96 811.02 1,100.81 1,291.98 399.50 640.53 687.54 375.50 358.59
Shareholders Equity (Total)
1,193.11 1,540.96 811.02 1,100.81 1,291.98 399.50 640.53 687.54 375.50 358.59
Shareholders Equity and Liabilities (Total)
1,297.23 1,663.20 937.12 1,238.72 1,437.74 852.95 890.74 858.46 614.40 619.09
Shares (Common)
58.45 57.16 55.95 55.04 54.33 69.29 68.40 58.22 48.83 42.22
Shareholders Equity (Tangible)
1,193.11 1,540.96 811.02 1,100.81 1,291.98 399.50 640.53 687.54 375.50 358.59
Net Debt
(854.42) (893.71) (776.93) (711.12) (1,019.74) (572.60) (564.20) (585.30) (423.94) (541.31)
Total Debt
— — — 72.00 0.28 0.33 0.67 — — —

Fold the line items

In millions of $ except per-share values · columns are period end dates